OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 78 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,961,530 | +36.1% | 239,800 | -0.5% | 0.01% | +33.3% |
| Q2 2023 | $2,175,327 | +204.5% | 240,900 | +17.0% | 0.01% | +200.0% |
| Q1 2023 | $714,473 | +28.8% | 205,900 | -9.1% | 0.00% | 0.0% |
| Q4 2022 | $554,680 | -47.7% | 226,400 | -41.1% | 0.00% | -33.3% |
| Q3 2022 | $1,061,000 | -49.3% | 384,500 | -25.2% | 0.00% | -50.0% |
| Q2 2022 | $2,091,000 | -20.3% | 513,800 | -16.5% | 0.01% | -14.3% |
| Q1 2022 | $2,622,000 | -50.7% | 615,400 | +8.3% | 0.01% | -46.2% |
| Q4 2021 | $5,316,000 | +1976.6% | 568,000 | +6007.5% | 0.01% | +1200.0% |
| Q3 2021 | $256,000 | – | 9,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |